Compare ALLO & SHBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALLO | SHBI |
|---|---|---|
| Founded | 2017 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 539.4M | 601.1M |
| IPO Year | 2018 | 1997 |
| Metric | ALLO | SHBI |
|---|---|---|
| Price | $2.44 | $18.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 3 |
| Target Price | $8.40 | ★ $19.17 |
| AVG Volume (30 Days) | ★ 4.3M | 184.5K |
| Earning Date | 03-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.70% |
| EPS Growth | 34.09 | ★ 34.85 |
| EPS | N/A | ★ 1.78 |
| Revenue | N/A | ★ $20,853,000.00 |
| Revenue This Year | N/A | $9.16 |
| Revenue Next Year | $140,929.80 | $6.71 |
| P/E Ratio | ★ N/A | $9.96 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.86 | $11.47 |
| 52 Week High | $2.80 | $20.68 |
| Indicator | ALLO | SHBI |
|---|---|---|
| Relative Strength Index (RSI) | 55.11 | 48.62 |
| Support Level | $2.20 | $17.32 |
| Resistance Level | $2.76 | $19.31 |
| Average True Range (ATR) | 0.20 | 0.50 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 56.06 | 66.67 |
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in one business segment- banking. The company's primary source of revenue is derived from interest earned on commercial, residential mortgage and other loans, and fees charged in connection with lending and other banking services located in Maryland, Delaware and Virginia.